| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/23/2008 | CN101108171A Budesonide intestines sustained release dextromethorphan pellets and method of manufacturing the same |
| 01/23/2008 | CN101108164A Bcg polyoses nucleic acid intralipid and its cryochem formulated product and use thereof |
| 01/23/2008 | CN101108000A Addition-application method of functional properties fat planting food mixture |
| 01/23/2008 | CN100363365C Immunomodulating heterocyclic compounds |
| 01/23/2008 | CN100363053C Intracellular isoform of the interleukin-1 receptor antagonist |
| 01/23/2008 | CN100363047C Animal immunity potentiator |
| 01/23/2008 | CN100363022C Pharmaceutical composition with immunoregulation function and method for preparing the same |
| 01/23/2008 | CN100362994C Preparation for treating allergic rhinitis and asthma |
| 01/22/2008 | US7321059 2,3-diethoxylated propionic acid derivatives, e.g., 20-(7,10,13,16-tetraoxaheptadec-1-yloxy)-2,5,8,11,18-pentaoxahenicosan-21-oic acid; for use in inhalation therapy with propellants for treating respiratory system disorders |
| 01/22/2008 | US7321026 Framework-patched immunoglobulins |
| 01/22/2008 | US7320999 Immunosuppressants, organ transplantation, autoimmune diseases, rheumatic diseases |
| 01/22/2008 | US7320993 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic useful as cytostatic and immuosuppressive agents |
| 01/22/2008 | US7320982 Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-β 1 |
| 01/22/2008 | US7320964 Modulation of expression of STAT-1 dependent genes |
| 01/22/2008 | US7320873 for diagnosing autoimmune disease (rheumatoid arthritis) activity using monoclonal antibodies |
| 01/22/2008 | US7320869 Antibodies to Chemokine Alpha-5 |
| 01/22/2008 | US7320793 Comprises ordered and repetitive antigen or antigenic determinant array for developing vaccines for treatment of infectious diseases, allergies and cancer; microarrays |
| 01/22/2008 | CA2495967C New synthesis process and new crystalline form for agomelatine, and pharmaceutical compositions containing it |
| 01/22/2008 | CA2392168C Vitamin d analogues |
| 01/22/2008 | CA2368348C Biodegradable, injectable oligomer-polymer composition |
| 01/22/2008 | CA2333322C Nitric oxide synthase inhibitors |
| 01/22/2008 | CA2283101C Quinoline leukotriene antagonists |
| 01/22/2008 | CA2257133C Human dnase i hyperactive variants |
| 01/22/2008 | CA2215520C Chlamydia vaccines |
| 01/22/2008 | CA2195419C Immunological activity of rhamnolipids |
| 01/17/2008 | WO2008008770A2 6, 9-disubstituted purine derivatives and their use for treating skin |
| 01/17/2008 | WO2008008549A2 Combination of an immunosuppressive agent and nonsteroidal anti -inflammatory drugs to treat neoplasia |
| 01/17/2008 | WO2008008453A1 Heterocyclic substituted piperazine compounds with cxcr3 antagonist activity |
| 01/17/2008 | WO2008008359A2 Benzofuro-and benzothienopyryimidine modulators of the histamine h4 receptor |
| 01/17/2008 | WO2008007804A1 ANTIHUMAN α9 INTEGRIN ANTIBODY AND USE OF THE SAME |
| 01/17/2008 | WO2008007711A1 Sart3-derived peptide useful in cancer vaccine therapy for hla-a3 supertype allele-positive prostate cancer patient |
| 01/17/2008 | WO2008007691A1 Salt of morpholine compound |
| 01/17/2008 | WO2008007476A1 Method for production of limulus-positive glycolipid, limulus-positive glycolipid, and limulus-positive glycolipid blend |
| 01/17/2008 | WO2008006895A2 Methods and compositions for increasing the efficiency of therapeutic antibodies using gamma delta t cell activators |
| 01/17/2008 | WO2008006795A2 Indole compounds |
| 01/17/2008 | WO2008006790A1 Indole compounds |
| 01/17/2008 | WO2007117577A3 High affinity human antibodies to human il-18 receptor |
| 01/17/2008 | WO2007098557A8 Regulation of immune responses by modulation of the function of antigen presenting cells |
| 01/17/2008 | WO2003004615A3 Secreted proteins |
| 01/17/2008 | US20080015347 Kind Of Fusion Protein, Gene Encoding It, Expression Method And Use Thereof |
| 01/17/2008 | US20080015340 Fusion protein of antigens from parainfluenza virus (PIV) and respiratory syncytial virus (RSV); single recombinant immunogen can protect susceptible individuals against diseases caused by both PIV and RSV |
| 01/17/2008 | US20080015261 Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment of delayed graft function |
| 01/17/2008 | US20080015247 quercetin, vitamin B3, and vitamin C as only ingredients, specified weight ratio; dietary supplement or a pharmaceutical formulation; free radical induced diseases |
| 01/17/2008 | US20080015200 Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptor |
| 01/17/2008 | US20080015185 N-heterocyclic inhibitors of tnf-alpha expression |
| 01/17/2008 | US20080015177 S1P receptor modulating compounds and use thereof |
| 01/17/2008 | US20080015175 Nontoxic; inhibition of interleukin-1 beta -converting enzyme |
| 01/17/2008 | US20080015172 Caspase inhibitors and uses thereof |
| 01/17/2008 | US20080015169 Amino-methyl substituted tetracycline compounds |
| 01/17/2008 | US20080015155 Compositions and Methods for the Treatment of Inflammatory Conditions of the Mucosae, Skin and the Eye |
| 01/17/2008 | US20080015149 Galectin 11 |
| 01/17/2008 | US20080014291 Process for the Production of Multi-Component Mineral Substance Preparations |
| 01/17/2008 | US20080014281 Chitin Micro-Particles As An Adjuvant |
| 01/17/2008 | US20080014246 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 01/17/2008 | US20080014242 Synthetic Bone Substitute Material |
| 01/17/2008 | US20080014227 Heterocyclic compounds based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
| 01/17/2008 | US20080014214 Composition and Method for Inducing Protective Vaccine Response Using SDF-1 |
| 01/17/2008 | US20080014209 Peptide mimics of conserved Gonococcal epitopes and methods and compositions using them |
| 01/17/2008 | US20080014189 Diaminotriazoles useful as inhibitors of protein kinases |
| 01/17/2008 | US20080014174 Method for treating tumors, infectious diseases, and autoimmune diseases with an activated HLA matching donor-originating lymphocyte |
| 01/17/2008 | US20080014141 Substance Binding Human Igg Fc Receptor Iib (Fcyriib) |
| 01/17/2008 | CA2658417A1 Heterocyclic substituted piperazine compounds with cxcr3 antagonist activity |
| 01/17/2008 | CA2658222A1 Methods and compositions for increasing the efficiency of therapeutic antibodies using .gamma. .delta. t cell activators |
| 01/17/2008 | CA2657133A1 Anti-human .alpha.9 integrin antibody and use of the same |
| 01/17/2008 | CA2551163A1 Methods for treating inflammatory, autoimmune or bone resorption diseases |
| 01/16/2008 | EP1878748A2 Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 costimulatory antigens |
| 01/16/2008 | EP1878738A1 Allergy-suppressive composition, allergy-suppressive food and allergy-suppressive agent |
| 01/16/2008 | EP1878441A2 Complement pathway inhibitors binding to C5 and C5a without preventing the formation of C5b |
| 01/16/2008 | EP1878440A1 Methods and compositions for increasing the efficiency of therapeutic antibodies using gamma delta cell activator compounds |
| 01/16/2008 | EP1878421A1 External preparation for skin |
| 01/16/2008 | EP1877406A1 New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents |
| 01/16/2008 | EP1877071A1 Method of improving immune function in mammals using 3-hpa producing lactobacillus strains in combination with medium chain triglyceride oil |
| 01/16/2008 | EP1877070A2 Dosage of oligonucleotides |
| 01/16/2008 | EP1625126B1 Imidazo and thiazolopyridines as jak3 kinase inhibitors |
| 01/16/2008 | EP1492793B1 New-4-(pyrrolopyrimidin-6-yl)benzenesulphonamide derivatives |
| 01/16/2008 | EP1392306B1 Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases |
| 01/16/2008 | EP1326894B1 Novel tumor-associated marker |
| 01/16/2008 | EP1326639B1 Adjuvant composition comprising an immunostimulatory oligonucleotide and a tocol |
| 01/16/2008 | EP1322656B1 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 01/16/2008 | EP1315793B1 Methods for culturing human lung mast cells and uses thereof |
| 01/16/2008 | EP1278532B1 Plant extract of the olea europaea species as no-synthase inhibitor and uses |
| 01/16/2008 | EP1261694B1 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
| 01/16/2008 | EP1255562B1 Use of opri lipoprotein from pseudomonas as a th1 inducing natural adjuvant for heterologous antigens |
| 01/16/2008 | EP1085848B1 Inhibitors of transcription factor nf-kappa b |
| 01/16/2008 | EP0898577B1 STREPTOCOCCUS PNEUMONIAE METHIONYL tRNA SYNTHETASE |
| 01/16/2008 | EP0837927B1 Anti-cd80 antibodies |
| 01/16/2008 | CN101107239A N-[(4, 5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, sulfonamide, carbamate and urea) derivatives as cannabinoid CB1 receptor antagonists |
| 01/16/2008 | CN101107233A 1H-imidiazole derivatives as cannabinoid CB2 receptor modulators |
| 01/16/2008 | CN101104648A Polyglucose and its extracting method and application |
| 01/16/2008 | CN101104632A Antisense oligonucleotide using apoptosis gene Caspase-4 as drone and use thereof |
| 01/16/2008 | CN101104075A Genetically engineered wine-brewing yeast live vaccine and its preparation method and application |
| 01/16/2008 | CN101104054A Method for preparing oral liquid for treating digestive system disease |
| 01/16/2008 | CN101104006A Method for preparing Chinese caterpillar fungus extracting concentrated liquid and application thereof |
| 01/16/2008 | CN101104002A Application of fly maggot protein powder in preparing anti-fatigue and immunity-improving product |
| 01/16/2008 | CN101103981A Medicinal composition containing tacrolimus |
| 01/16/2008 | CN101103832A Schisandra chinensis nucleic acid beverage |
| 01/16/2008 | CN101103819A Selenium germanium peptide biscuit |
| 01/16/2008 | CN101103752A Bamboo charcoal bag health-care tea |
| 01/16/2008 | CN100361710C Construction and application of oncolytic adenovirus recombinant of tumor cell specifically expressing immunoregulation factor GM-CSF |
| 01/15/2008 | US7319150 Method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |